ATE64095T1 - Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. - Google Patents
Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.Info
- Publication number
- ATE64095T1 ATE64095T1 AT87100203T AT87100203T ATE64095T1 AT E64095 T1 ATE64095 T1 AT E64095T1 AT 87100203 T AT87100203 T AT 87100203T AT 87100203 T AT87100203 T AT 87100203T AT E64095 T1 ATE64095 T1 AT E64095T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon atoms
- imidazochinazolines
- treat
- group
- nephritis
- Prior art date
Links
- 201000008383 nephritis Diseases 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 imidazoquinazoline compound Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP301986 | 1986-01-10 | ||
| EP87100203A EP0230234B1 (de) | 1986-01-10 | 1987-01-09 | Verwendung von Imidazochinazolinen zur Behandlung und Verhinderung von Nephritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE64095T1 true ATE64095T1 (de) | 1991-06-15 |
Family
ID=11545619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT87100203T ATE64095T1 (de) | 1986-01-10 | 1987-01-09 | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4766126A (de) |
| EP (1) | EP0230234B1 (de) |
| JP (1) | JP2525787B2 (de) |
| KR (1) | KR870006898A (de) |
| AT (1) | ATE64095T1 (de) |
| DE (1) | DE3770481D1 (de) |
| PH (1) | PH23966A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT66324A (en) * | 1991-07-29 | 1994-11-28 | Warner Lambert Co | Quinazoline derivatives as acetylcholinesterase inhibitors and pharmaceutical compositions containing them |
| US5707621A (en) * | 1994-08-31 | 1998-01-13 | Chugai Pharmaceutical Co., Ltd. | Supression of nephritis-induced protein excretion by anti-IL-8 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS604186A (ja) * | 1983-06-21 | 1985-01-10 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン化合物 |
| JPS6028979A (ja) * | 1983-07-14 | 1985-02-14 | Dai Ichi Seiyaku Co Ltd | イミダゾキナゾリン類化合物 |
-
1987
- 1987-01-06 US US07/000,800 patent/US4766126A/en not_active Expired - Fee Related
- 1987-01-09 PH PH34703A patent/PH23966A/en unknown
- 1987-01-09 JP JP62003052A patent/JP2525787B2/ja not_active Expired - Lifetime
- 1987-01-09 EP EP87100203A patent/EP0230234B1/de not_active Expired - Lifetime
- 1987-01-09 DE DE8787100203T patent/DE3770481D1/de not_active Expired - Lifetime
- 1987-01-09 AT AT87100203T patent/ATE64095T1/de active
- 1987-01-10 KR KR870000136A patent/KR870006898A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2525787B2 (ja) | 1996-08-21 |
| DE3770481D1 (de) | 1991-07-11 |
| US4766126A (en) | 1988-08-23 |
| PH23966A (en) | 1990-01-23 |
| EP0230234B1 (de) | 1991-06-05 |
| EP0230234A1 (de) | 1987-07-29 |
| JPS62252724A (ja) | 1987-11-04 |
| KR870006898A (ko) | 1987-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG105271A (bg) | Производни на 1h-имидазопиридин | |
| DE68914292D1 (de) | Zusammensetzung zur Behandlung von ischämischen Störungen in Organen. | |
| DE3486150D1 (de) | Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. | |
| EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
| ATE184483T1 (de) | Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms | |
| DE3888340D1 (de) | Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit. | |
| ATE161725T1 (de) | Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina | |
| ATE64095T1 (de) | Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. | |
| DE68900516D1 (de) | Therapeutische mittel zur behandlung von magengeschwueren. | |
| DE3867652D1 (de) | N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems. | |
| ATE237611T1 (de) | Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer | |
| ATE52506T1 (de) | Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung. | |
| DK0420224T3 (da) | Anthihepatopatisk middel | |
| ES528461A0 (es) | Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles | |
| NO870423L (no) | 5-substituerte oktahydroindolizin-analgetiske forbindelser og 7-keto mellomprodukter. | |
| ATE132038T1 (de) | Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn | |
| DE69619088D1 (de) | Quinoxalin-Derivate zur Behandlung von Tinnitus | |
| ATE81466T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz. | |
| DK0413278T3 (da) | Anvendelse af xanthinderivater mod mavesår | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| ATE96318T1 (de) | Acylaminoalkylpyridinamide als inhibitoren der tumormetastasierung. | |
| ATE81465T1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. | |
| DE3662039D1 (de) | Novel diamine derivatives | |
| ATE61343T1 (de) | Analoga von 3-phenoxy(oder phenylthio)cyclopentancarbonylaminosaeure. | |
| DE69424677D1 (de) | Präparat zur behandlung der drogenabhängigkeit |